An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease.
Click here for original story, Oral antiviral drug effective against respiratory syncytial virus (RSV)
Source: ScienceDaily